FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present in-person at the following investor conferences in New York City: Morgan Stanley 20th Annual Global Healthcare … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences. Citi’s 17th Annual BioPharma Conference (Attending) Tuesday – … [Read more…]
$40,000 to be awarded NEW YORK–(BUSINESS WIRE)–$MPLN #MPLN–MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”) is accepting applications for its Rural Health Grant. The grant provides financial resources to help healthcare providers in rural areas introduce or expand services, education, screenings and other programs aimed at improving the health of people in their communities. The MultiPlan … [Read more…]
Gabriel Rincon aims to help HMRI double in size PASADENA, Calif.–(BUSINESS WIRE)–Huntington Medical Research Institutes (HMRI), an independent, nonprofit medical research organization in Southern California, has appointed Gabriel Rincon as the company’s chief financial officer and treasurer, effective July 2022. “We welcome Gabe as our new CFO and look forward to his contributions to HMRI’s … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Air Ionizer Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The air ionizer market is poised to grow by $900.2 million during 2022-2026, accelerating at a CAGR of 7.14% during the forecast period. The report on the air ionizer market provides a holistic analysis, market size and forecast, trends, growth drivers, … [Read more…]
Quidel’s QuickVue® assay named “Official At-Home COVID Test of the Los Angeles Rams” SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (“Quidel”), a subsidiary of QuidelOrtho Corporation (NASDAQ: QDEL) and a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and the World Champion Los Angeles Rams today announced a multi-year partnership agreement to … [Read more…]
The regenerative biotechnology is reducing healing times to as little as three weeks in Mohs-related surgical wounds PHOENIX–(BUSINESS WIRE)–#biosciences—Dermistat™, one of the latest wound healing innovations by BioLab Sciences, a regenerative biotechnology company, has emerged as the go-to wound healing option for dermatologists throughout the country. Introduced earlier this year, Dermistat™ is a revolutionary regenerative … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “U.S. Endoscope Repair Market Report: By Type, Service Provider – Size, Share Analysis and Growth Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. In 2021, the U.S. endoscope repair market was valued at $405.6 million, and it is set to reach $990.7 million by 2030, growing at a compound annual growth … [Read more…]
Mental health, food insecurity and economic concerns identified in the 2022 assessment survey, with COVID-19 having significant impact LOS ANGELES–(BUSINESS WIRE)–#childrenshealth—Children’s Hospital Los Angeles (CHLA) completed the 2022 Community Health Needs Assessment (CHNA), part of the hospital’s continual commitment to better understand the health of its primary “neighborhood” – Los Angeles County – and the … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Interventional Vascular Consumables Market Research Report: By Type, Product Type – Revenue Estimation and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. From an estimated $3,929.2 million in 2021, the interventional vascular consumables market revenue is predicted to grow to $5,501.7 million by 2030, at a CAGR of 3.8%. Since interventional … [Read more…]
